Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes
Ofri Mosenzon, Meir Schechter, Gil Leibowitz
Topics & Concepts
MedicineSemaglutideAlbuminuriaType 2 diabetesGlucagon-like peptide 1 receptorKidney diseaseKidneyDiabetes mellitusInternal medicineRenal functionGlucagon-like peptide-1EndocrinologyReceptorAgonistLiraglutideDiabetes Treatment and ManagementPancreatic function and diabetesDiabetes Management and Research